August 8th 2024
Digital therapeutics help kids build emotional regulation and coping skills, supporting pediatric care while waiting for specialized mental health services.
Transdermal delivery of methylphenidate passes a test of efficacy in ADHD
June 8th 2006New research reported at the annual meeting of the American Psychiatric Association in Toronto in May shows that Shire Pharmaceutical Group's methylphenidate transdermal system (Daytrana) appears a safe and well-tolerated alternative to OROS methylphenidate, and is equally efficacious.
ADHD study supports lower lead exposure limits
May 1st 2006A new study on potential interactions between genetic and environmental factors in ADHD suggests that current limits on lead exposure are too high. Lead exposure below the current limits allowed by Environmental Protection Agency regulations produced measurable impairment of executive functions, especially in boys, who have a specific variation in the DRD4 dopamine receptor gene.
Case in Point: A Young Girl With Cafe au Lait Spots
April 1st 2006A 9-year-old girl presents with multiple hyperpigmented lesions, some of which have been present since birth (Figure 1). The lesions have increased in size and number. There is no history of seizures. Her 40-year-old mother has multiple skin nodules (Figure 2).
Study: Ritalin effective in preschoolers with ADHD
October 10th 2005The longest and most complex study of methylphenidate (Ritalin) in preschool children shows that it can be safe and effective for some children in that age group who have attention deficit hyperactive disorder (ADHD), according to the study's lead author.
FDA extends indication for ADHD treatment formulation to adolescent years
October 5th 2005The US Food and Drug Administration (FDA) recently approved Adderall XR (an extended-release formulation of mixed salts of amphetamine) as a once-daily treatment for attention deficit hyperactivity disorder in adolescents 13 to 17 years old. That action bridges an "indication gap" between earlier approval of the product for patients 6 to 12 years old and for older (18 years) adolescents and adults.
Where we are, and how well we can succeed, at treating ADHD
December 1st 2003At pediatricians' disposal today are numerous formulations of approved medications for ADHD--traditional psychostimulants and newer agents. We also have developed an appreciation of the value of a multipronged approach to this chronic disorder.
"At least it's natural...." Herbs and dietary supplements in ADHD
September 1st 2000Parents increasingly are turning to alternative therapies to manage their child's ADHD. This review of the pharmacology an toxicology of the most popular herbs and dietary supplements for treating ADHD and what the literature shows about their efficacy should help you advise parents.